List view / Grid view
The clinical trial is at the core of pharmaceutical research. And yet, despite the advance of the industry, the experience of the patient taking part in a trial is not often an element considered for innovation.
With no currently approved medicines for the prevention of bronchopulmonary dysplasia (BPD) in extremely pre-term infants, a new pharmaceutical collaboration could produce the first major therapeutic breakthrough for this patient group in decades.
The CEO of PQE Group has formed a task force of employees in the corporate community to research and dispel fake news regarding COVID-19.
